U.S. panel rejects Philip Morris claim iQOS reduces disease risk

by reuter.com
http://ift.tt/pnED7n
(Reuters) - Philip Morris International Inc should not be allowed to claim that its iQOS electronic tobacco device can reduce the risks of tobacco-related diseases for smokers who completely switch from cigarettes, a U.S. Food and Drug Administration advisory panel concluded on Thursday.

Read more

Share on Facebook Share on Twitter Share on Google Plus

About New

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.